Robertson H. Gilliland serves as Executive at ADIAL PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Robertson H. Gilliland has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2018 involved exercising options for 29,931 shares valued at $0.
Robertson H. Gilliland currently holds 95,424 shares of ADIAL PHARMACEUTICALS, INC. (ADIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robertson H. Gilliland has been a net neutral trader of ADIL stock. They have purchased $0 and sold $0 worth of shares.
Robertson H. Gilliland's most recent insider trade was on Jul 31, 2018, when they sold 29,931 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |